Literature DB >> 24613671

Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.

Noemí Fabelo1, Virginia Martín1, Raquel Marín2, Dolores Moreno3, Isidre Ferrer3, Mario Díaz4.   

Abstract

The presence of lipid alterations in lipid rafts from the frontal cortex in late stages of Alzheimer's disease (AD) has been recently demonstrated. Here, we have isolated and analyzed the lipid composition of lipid rafts from different brain areas from control and AD subjects at initial neuropathologic stages. We have observed that frontal cortex lipid rafts are profoundly altered in AD brains from the earliest stages of AD, namely AD I/II. These changes in the lipid matrix of lipid rafts affected both lipid classes and fatty acids and were also detected in the entorhinal cortex, but not in the cerebellum from the same subjects. Paralleling these changes, lipid rafts from AD frontal and entorhinal cortices displayed higher anisotropy for environment-sensitive probes, indicating that lipid changes in AD lipid rafts increased membrane order and viscosity in these domains. The pathophysiological consequences of these alterations in the development and progression of AD were strengthened by the significant, and specific, accumulation of β-secretase within the lipid rafts of AD subjects even at the earliest stages. Our results provide a mechanistic connection between lipid alterations in these microdomains and amyloidogenic processing of amyloid precursor protein.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid precursor protein; Anisotropy; Docosahexaenoic acid; Entorhinal cortex; Frontal cortex; Lipid rafts; Membrane lipids; Membrane viscosity; Polyunsaturated fatty acids; β-secretase

Mesh:

Substances:

Year:  2014        PMID: 24613671     DOI: 10.1016/j.neurobiolaging.2014.02.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  49 in total

1.  Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats.

Authors:  Elena E Korbolina; Nikita I Ershov; Leonid O Bryzgalov; Natalia G Kolosova
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

Review 2.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

3.  The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging.

Authors:  Sarah E Hancock; Michael G Friedrich; Todd W Mitchell; Roger J W Truscott; Paul L Else
Journal:  Geroscience       Date:  2017-01-22       Impact factor: 7.713

Review 4.  The road to restoring neural circuits for the treatment of Alzheimer's disease.

Authors:  Rebecca G Canter; Jay Penney; Li-Huei Tsai
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 5.  Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise.

Authors:  Fei Yin
Journal:  FEBS J       Date:  2022-01-07       Impact factor: 5.622

6.  Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

Authors:  Richard D Semba
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

Review 7.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

8.  Plasmalemmal VDAC-1 corroborated as amyloid Aß-receptor.

Authors:  Friedrich P Thinnes
Journal:  Front Aging Neurosci       Date:  2015-09-30       Impact factor: 5.750

Review 9.  Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects.

Authors:  Femke M Feringa; Rik van der Kant
Journal:  Front Aging Neurosci       Date:  2021-06-24       Impact factor: 5.750

10.  ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.

Authors:  Nobutaka Sakae; Chia-Chen Liu; Mitsuru Shinohara; Jessica Frisch-Daiello; Li Ma; Yu Yamazaki; Masaya Tachibana; Linda Younkin; Aishe Kurti; Minerva M Carrasquillo; Fanggeng Zou; Daniel Sevlever; Gina Bisceglio; Ming Gan; Romain Fol; Patrick Knight; Miao Wang; Xianlin Han; John D Fryer; Michael L Fitzgerald; Yasumasa Ohyagi; Steven G Younkin; Guojun Bu; Takahisa Kanekiyo
Journal:  J Neurosci       Date:  2016-03-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.